Ingenuity Systems
PR Contact

Heidi Bullock
Director, Marketing
650.381.5150

Register to Start Using IPA Now

Quickly understand and validate the genes, proteins and pathways involved in your experiments. Discover additional targets, biomarkers and biological relationships that you may not have previously identified.

Register to Start Using IPA Now
 

Ingenuity Systems U.S. User Group Meeting
Sofitel Le Mediterranee
Cannes, France
24-25 April 2008

Workstations will be available for live demos during the breaks and lunch
Thursday, April 24
   
8:30 am Registration and Continental Breakfast
9:00

IPA Workshops

  • Core Analysis
  • Tox Analysis
  • Biomarker Analysis
  • Search & Explore (including Path Designer)
10:15 Morning Break
10:30 IPA Workshops continue

12:00

Luncheon at Chez Panisse
1:00 Welcome
Brian Dron, Ph.D., Director, European Operations Ingenuity Systems
1:15 IPA Roadmap & Ingenuity New Ventures
Ramon Felciano, Ph.D., Founder, CTO and VP Research, Ingenuity Systems
1:45 Keynote Speaker Improving Target Identification, Selection and Validation in Drug Discovery
Mike Trower, Head Discover Technology Group, Stevenage Molecular Discovery Research, GlaxoSmithKline
2:15 Differential Signaling Through the Insulin Receptor Analyzed by Gene Microarray Profiling
Pierre De Meyts, M.D., Ph.D., Corporate VP, Scientific Director, Receptor Systems Biology Laboratory, Hagedorn Research Institute
2:45 Afternoon Break
3:15 Ingenuity Knowledge Acquisition and Infrastructure
Kambiz Karimi, Ph.D., Content Product Manager, Ingenuity Systems
3:45 Microarray Dissection of Molecular Mechanisms in an Animal Model of Schizophrenia: The Amphetamine Sensitized Mouse Model
Jan Torleif Pedersen, Ph.D., Head, Bioinformatics, H. Lundbeck A/S
4:15 Breakout Session Descriptions and Identification of Breakout Participants Breakout Room Locations: Breakout Sessions and Facilitators
  • Biomarker
  • Toxicology
  • Search & Exploration of Biological and Chemical Knowledge
5:00 Meeting Adjourns
6:00 Evening Social Event
   
Friday, April 25
   
8:15 am Continental Breakfast
8:45 Feature Voting Instructions (voting through lunch)
9:00 8IPA 6: New Solutions, Features & Content
Brigitte Ganter, Ph.D., Director of Product Management, Ingenuity Systems
9:30 IPA a Tool for Signaling Pathways Discovery by Combination of Transcriptomic and DNA Mapping/Genotyping Datas
Joël Lachuer, Ph.D., ProfileXpert, Neurobiotec Service INSERM
10:00 SCOPERTA: Supporting Drug Discovery with Networks and Pathways
Andreas Kremer, Ph.D., Head of Unit – Bioinformatics Siena Biotech S.p.A.
10:45 10:30 Morning Break
11:00 Rat Heart Transcriptomic Analysis in Response to Cardiotoxic and Non-Cardiotoxic Drugs, and the Benefit of Using Ingenuity to Support Interpretation
Jean-Christophe Hoflack, Ph.D., Lab Head TGX, Roche
11:30 Understanding Molecular Mechanisms: IPA’s Search & Explore Reveals Protein:Disease and Drug:Target:Pathway Associations
Deborah Riley, Ph.D., Lead, Field Application Scientist, Ingenuity Systems
12:15 pm Lunch
1:15 Patient Subpopulations in Schizophrenia and Bipolar Disorder: Understanding Underlying Disease Mechanisms to Identify Potentially More Effective Treatments
Dave Michalovich, Ph.D., Head of Drug Target Research, Curidium Medica
1:45 Big Data in Mid-Sized Pharma - Towards the Characterization of Exploratory Data Using IPA Stephen Rudd, Ph.D., Head of Bioinformatics, Orion Pharma
2:15

Breakout Session Reports

  • Biomarker
  • Toxicology
  • Search & Exploration of Biological and Chemical Knowledge
2:45 Feature Voting Results
Brigitte Ganter, Ph.D., Director of Product Management, Ingenuity Systems
3:00 Wrap-up and Adjourn
Brian Dron, Ph.D., Director, European Operations, Ingenuity Systems